Here’s an informative article from h+ magazine on how the FDA currently argues that culturing adult stem cells amounts to the creation of a new drug. This of course would mean long time lags for getting stem cell procedures approved, which has prompted the creation of at least two groups: the American Stem Cell Therapy Association (ASCTA) and Safe Stem Cells NOW! (both focused on adult stem cells).
It doesn’t make sense to me that my own cells would be considered a “drug,” but Dr. Christopher J. Centeno who was interviewed for this article by Stephen Coles says that “The FDA is working to protect the interests of Big Pharma.” Yikes — if that’s the case, it’s a huge setback for personalized medicine.
Sonia Arrison / Sonia Arrison is an author and policy analyst who has studied
the impact of new technologies on society for more than a decade. A Senior Fellow at the California-based Pacific Research Institute (PRI) and a columnist for TechNewsWorld, she is author of two previous books (Western Visions and Digital Dialog) as well as numerous PRI studies on technology issues. A frequent media contributor and guest, her work has appeared in many publications including CBS MarketWatch, CNN, Los Angeles Times, New York Times, Wall Street Journal, and USA Today. She was also the host of a radio show called "digital dialogue" on the Voice America network and has been a repeat guest on National Public Radio and CNN's Headline News.